Combined antiestrogen, antiangiogenic and anti-invasion therapy inhibits primary and metastatic tumor growth in the MMTVneu model of breast cancer

This publication has 39 references indexed in Scilit:

• Clinical translation of angiogenesis inhibitors
  Nature Reviews Cancer, 2002
• Combined effects on tumor growth and metastasis by anti-estrogenic and antiangiogenic therapies in MMTV-neu mice
  Gene Therapy, 2002
• Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer
  Nature Genetics, 2002
• Differential effects of angiostatin, endostatin and interferon-α1 gene transfer on in vivo growth of human breast cancer cells
  Gene Therapy, 2002
• Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu
  Oncogene, 2002
• Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo
  European Journal of Surgical Oncology, 2001
• Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models
  European Journal Of Cancer, 1996
• Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
  Published by Elsevier ,1996
• The matrix‐degrading metalloproteinases
  BioEssays, 1992
• Management of Advanced Breast Cancer
  Hormone Research, 1989